No Data
No Data
Sisram Med (01696.HK) plans to hold a board of directors meeting on August 21st to approve the interim performance.
Sisram Med (01696.HK) announced that it will hold a board of directors meeting on August 21, 2024 to consider and approve the interim performance of the company and its subsidiaries for the six months ending on June 30, 2024, the distribution of interim dividends (if any) and to deal with any other matters.
Sisram Med (01696) will distribute a final dividend of HK$0.158 per share on September 9th.
Sisram Med (01696) announced that it will distribute until December 2023 on September 9, 2024...
SISRAM MED: RECORD DATE AND WITHHOLDING TAX RATE IN CONNECTIONWITH THE PAYMENT OF 2023 FINAL DIVIDEND
HKEX Stock Market Live | Ec Healthcare (02138) fell more than 6%, leading the decline in the medical beauty concept. The demand for medical beauty is temporarily under pressure, and the growth in the second quarter is slightly under pressure.
Aesthetic medicine stocks collectively declined, as of press time, ec healthcare (02138) fell by 5.45%, at HKD 1.04; shanghai haohai biological technology (06826) fell by 4.56%, at HKD 30.35; sisram med (01696) fell by 3.69%, at HKD 3.13.
Aesthetic medicine stocks are under pressure, and Sisram Medical (01696) fell by 4.02%. Daiwa expects macro and policy factors to suppress the growth of cosmetic medicine companies in the second half of the year.
Aesthetic medicine concept stocks are under pressure, with Sisram Med (01696) falling 4.02%, Haohai Biotech (06826) falling 2.18%, Perfect Medical (01830) falling 1.92%, and Rui'er Group (06639) falling 1.39%. On the news side, Morgan Stanley's report pointed out that under the sustained anti-corruption factor in the mainland, the market is expected to have weak second-quarter performance of medical technology companies. Investors are concerned about the timing and scale of the upcoming central government's fiscal stimulus plan, which sets expectations for medical technology stocks for the second half of this year and next year. Meanwhile, macro and policy aspects
China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products
No Data